Search

Search Constraints

You searched for: Author/Creator Syrjanen, Jeremy

Search Results

1. [P1–254]: CHARACTERISTICS AND PROGRESS ON THE INITIAL 209 SUBJECTS IN THE LONGITUDINAL EVALUATION OF FAMILIAL FRONTOTEMPORAL DEMENTIA SUBJECTS (LEFFTDS) PROTOCOL. (1st July 2017)

2. [P1–317]: QUALITY OF LIFE AMONG SUBJECTS AND INFORMANTS IN FAMILIAL FRONTOTEMPORAL DEMENTIA: PRELIMINARY DATA IN THE LEFFTDS COHORT. (1st July 2017)

3. [P2–281]: CAREGIVER BURDEN IN FAMILIAL FRONTOTEMPORAL DEMENTIA SUBJECTS: PRELIMINARY DATA IN THE LEFFTDS COHORT. (1st July 2017)

4. [P2–317]: PHENOCONVERSION FROM ASYMPTOMATIC TO MINIMALLY SYMPTOMATIC FTLD: PRELIMINARY DATA IN THE LEFFTDS COHORT. (1st July 2017)

5. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint. Issue 1 (8th January 2020)

6. Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration. Issue 1 (6th January 2020)

7. F2‐02‐01: NEUROFILAMENT LIGHT CHAIN IN AD IN CSF AND BLOOD. (1st July 2006)

8. F4‐05‐02: COMPARISON OF VARIABLES ASSOCIATED WITH CSF NEUROFILAMENT, TOTAL‐TAU, AND NEUROGRANIN IN A COMMUNITY‐BASED STUDY. (1st July 2019)

9. Frontal lobe 1H MR spectroscopy in asymptomatic and symptomatic MAPT mutation carriers. (20th August 2019)

10. Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases. Issue 1 (8th January 2020)